
The Problem
More than 65 million Americans – nearly one in five – are uninsured or underinsured, leaving them vulnerable to one of the most pressing health inequity issues in the country: lack of access to essential medicine.
Patients living in poverty or working low-wage jobs often face impossible choices between food, rent, and life-sustaining prescriptions.
The consequences are staggering, 21% of adults report skipping or rationing medications due to cost (Kaiser Family Foundation study, 2023). Medication nonadherence contributes to an estimated 125,000 deaths and 10% of hospitalizations in the U.S. each year (Annals of Internal Medicine, 2018).
Impact Goals
The startup investment requested in this proposal will fund the essential infrastructure, staffing, and systems required to launch MAP USA and position the program for national scale.
Over the 12-18 month startup phase, MAP USA will:
- Serve at least 170,000 thirty-day prescriptions to uninsured and underinsured patients through partner clinics and pharmacies by the end of Year 1.
- Engage and onboard 10-15 new beta clinic partners and transition all 130+ existing partners to updated agreements, compliance protocols, and the new ordering platform by Month 18.
- Establish a core formulary of 30+ essential medicines and secure a minimum of three new manufacturer or distributor sourcing agreements by Month 12.
- Achieve a 4:1 return on philanthropic investment in medicine value delivered to partner sites by the end of the startup period.
- Maintain a 95% partner retention rate among clinics and pharmacies enrolled in MAP USA during the startup phase.
These startup deliverables will lay the groundwork for MAP USA to expand medicine access to hundreds of thousands more patients in the years ahead.
By Year 5, MAP USA anticipates:
- Serving 500,000 patients annually through 1,000+ partner clinics and pharmacies.
- Distributing $200 million in medicine-value annually, with emphasis on chronic disease and maternal health.
- Improving medication adherence, lowering avoidable ER visits, and increasing clinic capacity through consistent formulary access.
Currently serving 130 partner clinics in 9 states

Program Growth

